NO137205C - Analogifremgangsm}te for fremstilling av piperazinpyrimidiner med terapeutisk virkning. - Google Patents
Analogifremgangsm}te for fremstilling av piperazinpyrimidiner med terapeutisk virkning.Info
- Publication number
- NO137205C NO137205C NO3260/73A NO326073A NO137205C NO 137205 C NO137205 C NO 137205C NO 3260/73 A NO3260/73 A NO 3260/73A NO 326073 A NO326073 A NO 326073A NO 137205 C NO137205 C NO 137205C
- Authority
- NO
- Norway
- Prior art keywords
- pyrimidines
- piperazine
- preparation
- therapeutic effect
- analogical procedure
- Prior art date
Links
- -1 PIPERAZINE PYRIMIDINES Chemical class 0.000 title 1
- GLUUGHFHXGJENI-UHFFFAOYSA-N diethylenediamine Natural products C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 title 1
- 230000001225 therapeutic effect Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/42—One nitrogen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/47—One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/48—Two nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/52—Two oxygen atoms
- C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
- C07D239/545—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/56—One oxygen atom and one sulfur atom
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Anesthesiology (AREA)
- Hospice & Palliative Care (AREA)
- Otolaryngology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR7324874A FR2257294B1 (cs) | 1973-07-06 | 1973-07-06 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO326073L NO326073L (cs) | 1975-02-03 |
| NO137205B NO137205B (no) | 1977-10-10 |
| NO137205C true NO137205C (no) | 1978-01-18 |
Family
ID=9122191
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO3260/73A NO137205C (no) | 1973-07-06 | 1973-08-16 | Analogifremgangsm}te for fremstilling av piperazinpyrimidiner med terapeutisk virkning. |
Country Status (10)
| Country | Link |
|---|---|
| JP (1) | JPS5849548B2 (cs) |
| BE (1) | BE803803A (cs) |
| CH (1) | CH582171A5 (cs) |
| DE (1) | DE2342880A1 (cs) |
| ES (1) | ES418113A1 (cs) |
| FR (1) | FR2257294B1 (cs) |
| GB (1) | GB1434544A (cs) |
| LU (1) | LU68263A1 (cs) |
| MX (1) | MX2978E (cs) |
| NO (1) | NO137205C (cs) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH602663A5 (cs) * | 1975-05-23 | 1978-07-31 | Mar Pha Etu Expl Marques | |
| FR2417507A2 (fr) * | 1977-07-28 | 1979-09-14 | Ugine Kuhlmann | Diamino-2,4 (ou -4,6) methylthio-5 pyrimidines herbicides |
| JPS54159877A (en) * | 1978-06-07 | 1979-12-18 | Matsushita Electronics Corp | Detection method for semiconductor substrate position and break |
| FR2503162A1 (fr) * | 1981-04-07 | 1982-10-08 | Pharmindustrie | Nouveaux derives de piperazino-2 pyrimidine, procedes pour leur preparation et leur utilisation comme medicaments ou comme intermediaires pour la fabrication de medicaments |
| JPS6177335A (ja) * | 1984-09-25 | 1986-04-19 | Kazumichi Kimura | 半導体ペレツト不良マ−ク検出装置 |
| IT1191845B (it) * | 1986-01-20 | 1988-03-23 | Dompe Farmaceutici Spa | Alchiloli derivati farmacologicamente attivi |
| JPH02114936U (cs) * | 1989-03-03 | 1990-09-14 |
-
1973
- 1973-07-06 FR FR7324874A patent/FR2257294B1/fr not_active Expired
- 1973-08-16 NO NO3260/73A patent/NO137205C/no unknown
- 1973-08-20 BE BE134751A patent/BE803803A/xx not_active IP Right Cessation
- 1973-08-20 LU LU68263A patent/LU68263A1/xx unknown
- 1973-08-22 ES ES418113A patent/ES418113A1/es not_active Expired
- 1973-08-23 CH CH1213673A patent/CH582171A5/xx not_active IP Right Cessation
- 1973-08-24 DE DE19732342880 patent/DE2342880A1/de not_active Ceased
- 1973-09-06 JP JP48100728A patent/JPS5849548B2/ja not_active Expired
- 1973-09-12 GB GB4286673A patent/GB1434544A/en not_active Expired
- 1973-11-08 MX MX003804U patent/MX2978E/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| NO326073L (cs) | 1975-02-03 |
| FR2257294A1 (cs) | 1975-08-08 |
| LU68263A1 (cs) | 1973-10-24 |
| MX2978E (es) | 1980-01-17 |
| GB1434544A (en) | 1976-05-05 |
| FR2257294B1 (cs) | 1977-07-01 |
| DE2342880A1 (de) | 1975-01-30 |
| CH582171A5 (cs) | 1976-11-30 |
| JPS5025578A (cs) | 1975-03-18 |
| BE803803A (fr) | 1974-02-20 |
| NO137205B (no) | 1977-10-10 |
| JPS5849548B2 (ja) | 1983-11-05 |
| ES418113A1 (es) | 1976-03-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO145273C (no) | N-formyl-alfa-l-aspartyl-l-fenylalanin for anvendelse til fremstilling av alfa-l-aspartyl-l-fenylalaninalkylestere | |
| SE423631B (sv) | Forfarande for framstellning av oxaalhyl-dialkylxantiner | |
| SE7710599L (sv) | Forfarande for framstellning av bensisoxazoler | |
| NO145056C (no) | (s)-1-aryloksy-2-propanolderivater for fremstilling av terapeutisk aktive (s)-1-aryloksy-3-amino-2-propanolderivater | |
| SE420604B (sv) | Forfarande for framstellning av oxazolderivat | |
| FI55846C (fi) | Foerfarande foer framstaellning av 8-azapurin-5-onderivat med terapeutisk anvaendning | |
| NO740606L (no) | Analogifremgangsmåte til fremstilling av terapeutisk virksomme 3-klor-7-alfa-amino-acylcefalosporinforbindelser. | |
| SE407575B (sv) | Forfarande for framstellning av 1,3-dioxanderivat med terapentisk verkan | |
| SE413244B (sv) | Forfarandefor framstellning av bensopyraner med analgetisk verkan | |
| SE396388B (sv) | Analogiforfrande for framstellning av 2,3-dihydro-oxo-imidazo-/1,2-a/pyrimidiner | |
| NO137387C (no) | Analogifremgangsm}te til fremstilling av 5-metyltiopyrimidiner med terapeutisk virkning | |
| NO146596C (no) | Fremgangsmaate for fremstilling av 6-deoksytetracykliner | |
| SE7712151L (sv) | Forfarande for framstellning av linkomycinderivat | |
| NO790627L (no) | Fremgangsmaate for fremstilling av hydroksyalkylxantiner | |
| NO153806C (no) | Fremgangsmaate for fremstilling av 6-deoksytetracyklin. | |
| SE398499B (sv) | Forfarande for framstellning av 2,4,5,6-tetrahydrocyklopenta/c/purrol-4-karboxamider och -4-tiokarboxamider med terapeutisk verkan | |
| SE409716B (sv) | Analogiforfarande for framstellning av 11beta-alkyl-delta4-estrener | |
| SE402456B (sv) | Analogiforfarande for framstellning av fenyletylaminderivat med anorexigen aktivitet | |
| NO136574C (no) | Analogifremgangsm}te for fremstilling av terapeutisk aktive pyrimidinderivater. | |
| NO140104C (no) | Analogifremgangsmaate til fremstilling av 17beta-hydroksy-16,16-dimetylestr-4-en-3-on med terapeutisk aktivitet | |
| NO140860C (no) | Analogifremgangsmaate for fremstilling av fysiologisk aktive triazolo-1,5-benzodiazepiner | |
| NO139125C (no) | Analogifremgangsmaate for fremstilling av cykloheksantetrolderivater | |
| NO740607L (no) | Analogifremgangsmåte til fremstilling av terapeutisk virksomme 7-acylamino-3-halogen-cefalosporinforbindelser. | |
| SE409994B (sv) | Forfarande for framstellning av amidinokarbamider | |
| DK136249C (da) | Analogifremgangsmade til fremstilling af xanthenderivater |